Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.4532
-0.0451 (-9.05%)
At close: Jul 2, 2026, 4:00 PM EDT
0.4540
+0.0008 (0.18%)
After-hours: Jul 2, 2026, 7:55 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $6.3 million as of July 2, 2026. Its market cap has decreased by -50.50% in one year.
Market Cap
6.30M
Enterprise Value
16.46M
1-Year Change
-50.50%
Ranking
Category
Stock Price
$0.45
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $6.30M, a decrease of -93.92%. That is a compound annual growth rate of -39.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 6.30M | -65.49% |
| Dec 31, 2025 | 18.25M | -27.79% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Co-Diagnostics | 10.94M |
| Phaos Technology Holdings (Cayman) Limited | 9.08M |
| HeartSciences | 8.89M |
| Sintx Technologies | 8.21M |
| Nexalin Technology | 7.78M |
| enVVeno Medical | 7.42M |
| Trinity Biotech | 7.23M |
| Beyond Air | 6.74M |